Drug Landscape ›
povidone- iodine solution. ›
Regulatory · United States
Marketing authorisation
FDA
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
Window: 20 April 2025 – 20 April 2026
Total reports: 7
Most-reported reactions
Myelosuppression — 2 reports (28.57%) Neutropenia — 1 report (14.29%) Pneumocystis Carinii Pneumonia — 1 report (14.29%) Pneumonia Viral — 1 report (14.29%) Pneumonitis — 1 report (14.29%) Thrombocytopenia — 1 report (14.29%)
Source database →
povidone- iodine solution. in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is povidone- iodine solution. approved in United States?
Yes. FDA has authorised it.
Who is the marketing authorisation holder for povidone- iodine solution. in United States?
Erzincan Military Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.